If the order goes through, total cost to acquire and exercise: $675,316.446
Value of holding at closing price of $0.215: $715,236.63
They have the option of either flipping it for roughly $40,000 or holding for the expected toxicity results and start of Phase 1 human trials.
Ann: Appendix 2A, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.205M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 190000 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 20000 | 1 |
View Market Depth
| Last trade - 07.00am 07/10/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable